SCHEDULE 13D

Company

Enveric Biosciences, Inc.

Filed

November 8, 2018

Accession Number

0001607062-18-000390

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →